World Library  
Flag as Inappropriate
Email this Article

Incontinentia pigmenti

Article Id: WHEBN0001212374
Reproduction Date:

Title: Incontinentia pigmenti  
Author: World Heritage Encyclopedia
Language: English
Subject: List of MeSH codes (C16), List of genetic disorders, List of MeSH codes (C17), List of cutaneous conditions, Phakomatosis
Collection: Enzyme Defects, Eosinophilic Cutaneous Conditions, X-Linked Dominant Disorders
Publisher: World Heritage Encyclopedia

Incontinentia pigmenti

Incontinentia pigmenti
Classification and external resources
ICD-10 Q82.3
ICD-9-CM 757.33
OMIM 308300
DiseasesDB 29600
MedlinePlus 001583
eMedicine article/1114205 article/1176285
MeSH D007184
  • Incontinentia pigmenti

Incontinentia pigmenti (IP, also known as "Bloch–Siemens syndrome,"[1] "Bloch–Sulzberger disease,"[2] "Bloch–Sulzberger syndrome"[1] "melanoblastosis cutis," and "nevus pigmentosus systematicus") is a genetic disorder that affects the skin, hair, teeth, nails, and central nervous system. It is named due to its microscopic appearance.


  • Presentation 1
  • Diagnosis 2
  • Genetics 3
  • History 4
  • See also 5
  • References 6
  • External links 7


Incontinentia pigmenti forming along Blaschko's lines in a 3-year-old girl.

The skin lesions evolve through characteristic stages:

  1. blistering (from birth to about four months of age),
  2. a wart-like rash (for several months),
  3. swirling macular hyperpigmentation (from about six months of age into adulthood), followed by
  4. linear hypopigmentation.

Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Some patients have retinal vascular abnormalities predisposing to retinal detachment in early childhood. Cognitive delays/mental retardation are occasionally seen.

Discolored skin is caused by excessive deposits of melanin (normal skin pigment). Most newborns with IP will develop discolored skin within the first two weeks. The pigmentation involves the trunk and extremities, is slate-grey, blue or brown, and is distributed in irregular marbled or wavy lines. The discoloration sometimes fades with age.

Neurological problems can include: cerebral atrophy, the formation of small cavities in the central white matter of the brain, and the loss of neurons in the cerebellar cortex. About 20% of children with IP will have slow motor development, muscle weakness in one or both sides of the body, mental retardation, and seizures. They are also likely to have visual problems, which can include: crossed eyes, cataracts, and severe visual loss. Dental problems are common, and include missing or peg-shaped teeth - patients with IP often keep milk teeth into adult life.

Breast anomalies can occur in 1% of patients; anomalies can include hypoplasia and supernumerary nipples.

Skeletal and structural anomalies can occur in approximately 14% of patients, including:


The diagnosis of IP is established by clinical findings and occasionally by corroborative skin biopsy. Molecular genetic testing of the NEMO IKBKG gene (chromosomal locus Xq28) reveals disease-causing mutations in about 80% of probands. Such testing is available clinically.

In addition, females with IP have skewed X-chromosome inactivation; testing for this can be used to support the diagnosis.

Many people in the past were misdiagnosed with a second type of IP, formerly known as IP1. This has now been given its own name - 'Hypomelanosis of Ito' (incontinentia pigmenti achromians). This has a slightly different presentation: swirls or streaks of hypopigmentation and depigmentation. It is not inherited and does not involve skin stages 1 or 2. Some 33–50% of patients have multisystem involvement — eye, skeletal, and neurological abnormalities. Its chromosomal locus is at Xp11, rather than Xq28.


IP is inherited in an X-linked dominant manner.[3][4] IP is lethal in most, but not all, males. A female with IP may have inherited the IKBKG mutation from either parent or have a new gene mutation. Parents may either be clinically affected or have germline mosaicism. Affected women have a 50% risk of transmitting the mutant IKBKG allele at conception; however, most affected male conceptuses miscarry. Thus, the expected ratio for liveborn children is 33% unaffected females, 33% affected females, and 33% unaffected males. Genetic counseling, prenatal testing, and preimplantation genetic diagnosis is available.

In females, the cells expressing the mutated IKBKG gene due to lyonization selectively die around the time of birth so the X-inactivation is extremely skewed.[5]

IP is caused by mutations in a gene called NEMO (NF-kappaB essential modulator).


This disorder was first reported by Bruno Bloch, a German dermatologist in 1926 and Marion Sulzberger, an American dermatologist in 1928.[6][7][8]

See also


  1. ^ a b Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby.  
  2. ^ M. B. Sulzberger (1927). Über eine bisher nicht beschriebene kongenitale Pigmentanomalie (incontinentia pigmenti).. Berlin: Archiv für Dermatologie und Syphilis. p. 154. 
  3. ^ Pettigrew R, Kuo HC, Scriven P, et al. (December 2000). "A pregnancy following PGD for X-linked dominant [correction of X-linked autosomal dominant] incontinentia pigmenti (Bloch-Sulzberger syndrome): case report". Hum. Reprod. 15 (12): 2650–2.  
  4. ^ "Incontinentia pigmenti. DermNet NZ". 
  5. ^ Smahi A, Courtois G, Vabres P, et al. (2000). "Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium". Nature 405 (6785): 466–72.  
  6. ^ Bloch-Sulzberger pigment dermatosis (Bruno Bloch) at Who Named It?
  7. ^ Bloch, B. (1926). "Eigentümliche, bisher nicht beschriebene Pigmentaffektion (incontinentia pigmenti)". Schweizerische medizinische Wochenschrift (Basel) 56: 404–5. 
  8. ^ Sulzberger, M.B. (1927). "Über eine bisher nicht beschriebene kongenitale Pigmentanomalie (incontinentia pigmenti)". Archiv für Dermatologie und Syphilis (Berlin) 154: 19–32.  

External links

  • Incontinentia Pigmenti
  • Incontinentia pigmenti France
  • Incontinentia Pigmenti Video
  • GeneReview/NIH/UW entry on Incontinentia Pigmenti
  • DermAtlas 166
  • Discussion/support/information on Incontinentia Pigmenti
  • Incontinentia Pigmenti Support Group
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.